BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15173916)

  • 1. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
    Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
    Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
    Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K
    Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa.
    Portale G; Peters JH; Hagen JA; Demeester SR; Gandamihardja TA; Tharavej C; Hsieh CC; Demeester TR
    Arch Surg; 2005 Jun; 140(6):570-4; discussion 574-5. PubMed ID: 15967904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.
    Moskaluk CA; Heitmiller R; Zahurak M; Schwab D; Sidransky D; Hamilton SR
    Hum Pathol; 1996 Nov; 27(11):1211-20. PubMed ID: 8912833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
    Duhaylongsod FG; Wolfe WG
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor expression in the mucosal tissue at the gastroesophageal junction.
    Trowbridge R; Mittal SK; Sharma P; Hunter WJ; Agrawal DK
    Exp Mol Pathol; 2012 Oct; 93(2):246-9. PubMed ID: 22664272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion.
    Horii T; Koike T; Abe Y; Kikuchi R; Unakami H; Iijima K; Imatani A; Ohara S; Shimosegawa T
    Scand J Gastroenterol; 2011 Jun; 46(6):710-9. PubMed ID: 21446884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
    Yamada M; Kushima R; Oda I; Mojtahed K; Nonaka S; Suzuki H; Yoshinaga S; Matsubara A; Taniguchi H; Sekine S; Saito Y; Shimoda T
    Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
    Dzinic SH; Mahdi Z; Bernardo MM; Vranic S; Beydoun H; Nahra N; Alijagic A; Harajli D; Pang A; Saliganan DM; Rahman AM; Skenderi F; Hasanbegovic B; Dyson G; Beydoun R; Sheng S
    PLoS One; 2019; 14(4):e0215089. PubMed ID: 31002675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.
    Wu TT; Watanabe T; Heitmiller R; Zahurak M; Forastiere AA; Hamilton SR
    Am J Pathol; 1998 Jul; 153(1):287-94. PubMed ID: 9665490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry.
    Laerum OD; Ovrebo K; Skarstein A; Christensen IJ; Alpízar-Alpízar W; Helgeland L; Danø K; Nielsen BS; Illemann M
    Int J Cancer; 2012 Aug; 131(3):558-69. PubMed ID: 21866548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
    Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
    Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
    Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.